65th ASH Annual Meeting & Exposition

Two abstracts on the preclinical drug candidate CS014 and CS585, respectively, will be presented at the 65th ASH Annual Meeting & Exposition organized by the American Society of Hematology, in San Diego, US, on December 9-12, 2023.